Segal V - Search Results

1

Review: Modes and Processes of Severe Plastic Deformation (SPD).

Segal V. Segal V. Materials (Basel). 2018 Jul 10;11(7):1175. doi: 10.3390/ma11071175. Materials (Basel). 2018. PMID: 29996494 Free PMC article. Review.

2

[Consensus on management of dyslipidemia in pediatrics].

Comité de Nutrición. Comité de Nutrición. Arch Argent Pediatr. 2015 Apr;113(2):177-86. doi: 10.5546/aap.2015.177. Arch Argent Pediatr. 2015. PMID: 25727831 Free article. Spanish.

3

Biology of orthodontic tooth movement and periodontal defects: an interdisciplinary exploration.

Segal V, Masella R, Meister M. Segal V, et al. Todays FDA. 2004 Mar;16(3):18-9. Todays FDA. 2004. PMID: 19248262 No abstract available.

4

Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program.

Brienza S, Bensmaïne MA, Soulié P, Louvet C, Gamelin E, François E, Ducreux M, Marty M, André T, de Braud F, Bleiberg H, Ségal V, Itzhaki M, Cvitkovic E. Brienza S, et al. Among authors: segal v. Ann Oncol. 1999 Nov;10(11):1311-6. doi: 10.1023/a:1008319600648. Ann Oncol. 1999. PMID: 10631458 Free article. Clinical Trial.

5

Dual enzyme multi-layer bioreactors: analytical modeling and experimental studies.

Segal V, Lamed R, Lotan N. Segal V, et al. Artif Cells Blood Substit Immobil Biotechnol. 1999 Jul;27(4):313-42. doi: 10.3109/10731199909117703. Artif Cells Blood Substit Immobil Biotechnol. 1999. PMID: 10427417

6

Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.

Levi-Schaffer F, Goldenhersh MA, Segal V, Nagler A. Levi-Schaffer F, et al. Among authors: segal v. Bone Marrow Transplant. 1997 Apr;19(8):823-8. doi: 10.1038/sj.bmt.1700734. Bone Marrow Transplant. 1997. PMID: 9134176

7

Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.

Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A. Levi-Schaffer F, et al. Among authors: segal v. Exp Hematol. 1997 Mar;25(3):238-45. Exp Hematol. 1997. PMID: 9091300

8

Prostaglandin E2 production by chronic graft-versus-host disease dermal fibroblasts.

Levi-Schaffer F, Baram D, Segal V, Garbuzenko E, Lew S, Mekori YA. Levi-Schaffer F, et al. Among authors: segal v. Immunol Lett. 1995 Nov;48(1):11-15. doi: 10.1016/0165-2478(95)02433-6. Immunol Lett. 1995. PMID: 8847084

9

Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.

Nagler A, Segal V, Slavin S, Levi-Schaffer F. Nagler A, et al. Among authors: segal v. Clin Exp Immunol. 1995 Jun;100(3):529-35. doi: 10.1111/j.1365-2249.1995.tb03733.x. Clin Exp Immunol. 1995. PMID: 7539727 Free PMC article.

10

[Liver transplantation, vascular complications, role of imaging, percutaneous therapeutic possibilities].

Cauquil P, Caillet H, Brunet AM, Segal V, Verdier JP, Cauquil M, Delaunay S, Ajavon Y, Tessier JP. Cauquil P, et al. Among authors: segal v. Ann Radiol (Paris). 1994;37(5):342-8. Ann Radiol (Paris). 1994. PMID: 7993020 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page